Message from our Chairman and CEO
We had an excellent year in 2019, as we reached 40 consecutive years of sales growth
SPY Fluorescence: improving visualization in breast reconstruction
With an aggressive form of breast cancer, Barbara Pink chooses bilateral mastectomy and bilateral breast reconstruction
Innovation and acquisitions
Adding innovative and complementary products to our portfolio to strengthen our market leadership
Growth and globalization
Medical education programs across our portfolios are designed to help improve patient outcomes
Financials
Learn more about our 2019 financial highlights
People and culture
Creating and investing in programs that foster a positive workplace experience
Global recognition
FORTUNE Best Workplaces (U.S.)
For Diversity, 2019
#1 out of 100 companies — recipient for the third consecutive year
For Women, 2019
#47 — recipient for the third time
FORTUNE World’s Most Admired Companies
#5 in 2020
Medical Products and Equipment — recipient for the 18th consecutive year
FORTUNE World’s Best Workplaces
#8 in 2019
out of 25 companies — recipient for the third time
FORTUNE 500 Largest U.S.-Based Companies
#233 in 2019
joined the list in 2003 — recipient for the 17th consecutive year
SYK Corp 2020-02-03